Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Prevention of NSAID-Associated Ulcers
NCT00542789Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric ulcer and duodenal ulcer comparing Placebo with Esomeprazole 20 mg (2 arms). Primary endpoint: Absence of Gastric and/or Duodenal Ulcer Throughout the Treatment Period at 24 weeks. Started Aug 2007; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT00542789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542789.